Treatment of Morbid Obesity by Intragastric Injections of Botulinum Toxin A. A Randomized, Double-blind, Placebo Controlled, Phase II-trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Jul 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 05 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 21 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 07 Feb 2014 New trial record